A fourth SARS-CoV-2 mRNA vaccine in strictly seronegative kidney transplant recipients

Kidney Int. 2022 Apr;101(4):825-826. doi: 10.1016/j.kint.2022.01.017. Epub 2022 Feb 12.
No abstract available

Publication types

  • Letter

MeSH terms

  • COVID-19 Vaccines / adverse effects
  • COVID-19* / prevention & control
  • Humans
  • Kidney Transplantation* / adverse effects
  • SARS-CoV-2
  • Transplant Recipients
  • Vaccines, Synthetic
  • mRNA Vaccines

Substances

  • COVID-19 Vaccines
  • Vaccines, Synthetic
  • mRNA Vaccines